ARCHIVES

Celebrex Studied As Potential Prevention Of Lung Cancer In High-Risk Populations

This article is from The Cancer Letter archive.

Vol. 24 No. 8 | August 31, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Should Examine Alternative Therapies TA Report Says

September 28, 1990

In Brief: City of Hope launches Hematologic Malignancies and Stem Cell Transplantation Institute

October 31, 2014

Solomon Garb’s Questions/Answers

December 19, 1980

Orders Still Accepted For 20th Anniversary Special Publication

July 19, 1991

The NCI director and acting FDA commissioner called for faster approval of cancer drugs in speech to FDA staff.

October 21, 2005

NCAB Needs Focus, Strong Membership To Better Advise NCI, Chairman Rimer Says

September 22, 1995